关键词：抑郁症；医疗疾病；抑郁药物
摘 要：The Depression Drugs market is growing at a steady rate. In 2013, the Americas dominated the market, where the major contribution was from the US, and this trend is expected to continue during the forecast period. The Americas was followed by the EMEA and APAC regions. There is a vast opportunity for vendors in this market to expand into the APAC region. The market is expected to witness an improvement in its growth rate and post a CAGR of 2.49 percent during the forecast period.
目 录：

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

03.1 Market Overview

03.2 Product Offerings

04. Market Research Methodology

04.1 Market Research Process

04.2 Research Methodology

05. Introduction

06. Market Landscape

06.1 Market Overview

06.2 Market Size and Forecast

06.3 Five Forces Analysis

07. Market Segmentation by Product Types

08. Market Segmentation by Category

09. Geographical Segmentation

10. Buying Criteria

11. Rate of Incidence and Prevalence

12. Market Growth Drivers

13. Drivers and their Impact

14. Market Challenges

15. Impact of Drivers and Challenges

16. Market Trends

17. Trends and their Impact

18. Vendor Landscape

18.1 Competitive Scenario

18.1.1 Key News

18.1.2 Mergers and Acquisitions

18.2 Vendors Ranking 2013

18.3 Other Prominent Vendors

19. Key Vendor Analysis

19.1 GlaxoSmithKline plc

19.1.1 Business Overview

19.1.2 Business Segmentation

19.1.3 Key Information

19.1.4 SWOT Analysis

19.2 Eli Lilly & Co.

19.2.1 Business Overview

19.2.2 Key Information

19.2.3 SWOT Analysis

19.3 Forest Laboratories Inc

19.3.1 Business Overview

19.3.2 Key Information

19.3.3 SWOT Analysis

19.4 Pfizer Inc.

19.4.1 Business Overview

19.4.2 Business Segmentation

19.4.3 Key Information

19.4.4 SWOT Analysis

20. Other Reports in this Series